The historical rank and industry rank for Vascular Biogenics's FCF Margin % or its related term are showing as below:
VBLT'
s FCF Margin % Range Over the Past 10 Years
Min: -4924.92 Med: -2801.24 Max: -74.31
Current: -3650.94
During the past 11 years, the highest FCF Margin % of Vascular Biogenics was -74.31%. The lowest was -4924.92%. And the median was -2801.24%.
VBLT's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -148.24
vs VBLT: -3650.94
Vascular Biogenics FCF Margin % Historical Data
The historical data trend for Vascular Biogenics's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Vascular Biogenics's FCF Margin %
For the Biotechnology subindustry, Vascular Biogenics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vascular Biogenics's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vascular Biogenics's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Vascular Biogenics's FCF Margin % falls into.
Vascular Biogenics FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Vascular Biogenics's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vascular Biogenics FCF Margin % Related Terms
Thank you for viewing the detailed overview of Vascular Biogenics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Vascular Biogenics (Vascular Biogenics) Business Description
Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VBLT has been successfully added to your 